Navigation Links
MiMedx to Present at Jefferies 2013 Global Healthcare Conference
Date:5/28/2013

KENNESAW, Ga., May 28, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the Jefferies 2013 Global Healthcare Conference in New York.  Parker H. "Pete" Petit, Chairman and CEO and Michael J. Senken , Chief Financial Officer, are scheduled to present on June 3, 2013 at 1:30 p.m. Eastern Daylight Time. A webcast of this presentation will be available on the Company's website, www.mimedx.com

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimally manipulated implant for homologous use. MiMedx® is the leading supplier of amniotic tissue, having supplied over 150,000 allografts to date to distributors and OEMs for application in the Wound Care, Surgical, Sports Medic
'/>"/>

SOURCE MiMedx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
2. MiMedx Announces Record First Quarter 2013 Results
3. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
4. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
5. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
6. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
7. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
8. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
9. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
10. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
11. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Budding Biomedical Scientists ... University School participated in the Scientific Enrichment ... University’s School of Medicine . , ... unparalleled professional experience in the sciences and brings ... faculty and students for both academic and career ...
(Date:8/26/2014)... , Aug. 26, 2014  NeuroSigma, Inc., a ... to develop bioelectronic technologies, today announced that it has ... U.S. Securities and Exchange Commission relating to a proposed ... of shares to be offered and the price range ... Jefferies LLC will act as the book-running ...
(Date:8/26/2014)... Aug. 26, 2014 An analysis by Replikins, ... all Mers CoV virus strains has revealed ... to 2012.  This conservation and sharing of specific Replikin ... CoV Blocker-Vaccine™ candidate, as it did for the H5N1 ... of which have been found to be effective (1,2). ...
(Date:8/26/2014)... engineers from Singapore has successfully piloted the world,s ... communications. , With the weight of payloads being ... lightweight, low power-consuming, wireless communication system to do ... been a challenge for system designers. , The ... Nanyang Technological University in Singapore launched VELOX-I, which ...
Breaking Biology Technology:Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2ZigBee in the Sky 2
... /PRNewswire/ - Cytochroma today announced that it,has appointed ... Affairs and Quality Assurance. Dr. Engel brings to ... and quality assurance,and will be responsible for directing ... that the Company has appropriate quality,systems in place. ...
... VLP vaccines gains momentum with launch of a Phase ... IIa study of Seasonal Influenza Vaccine, ... ) announced today vaccination of healthy volunteers in a Phase,II ... The Phase IIa randomized, placebo controlled clinical trial will,evaluate the ...
... Sept. 16 Accuray,Incorporated (Nasdaq: ARAY ), a ... its president and chief executive officer, Euan S.,Thomson, Ph.D., ... Sciences,Conference in New York City, on Thursday, September 25, ... live webcast of the presentation will be available online ...
Cached Biology Technology:Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance 2Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 2Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 3Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 4Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate 5Accuray Incorporated's CEO to Speak at UBS Global Life Sciences Conference 2
(Date:8/27/2014)... researchers have identified a gene that could help scientists ... protein in the cell membrane of plants that senses ... conservation machinery accordingly. , "It,s similar to a ... at Duke. , The findings, which appear Aug. ... it easier to feed the world,s growing population in ...
(Date:8/27/2014)... requires nerve cells to rearrange existing patterns of activity ... patterns, a study of monkeys has found. The scientists ... electrical activity of brain cell networks. The study was ... "We looked into the brain and may have seen ... said Aaron Batista, Ph.D., an assistant professor at the ...
(Date:8/27/2014)... invasive grass species frequently found in forests has created ... on American toads, a new University of Georgia study ... to the U.S. in the early 1900s, is one ... to more than a dozen states in the past ... and in forests, it can survive in widely diverse ...
Breaking Biology News(10 mins):Water 'thermostat' could help engineer drought-resistant crops 2Scientists plug into a learning brain 2Scientists plug into a learning brain 3More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3
... One fifth of the standard dose of a commonly ... the full dose. This new finding should allow scarce ... in Africa. In a study initiated by the ... research arm of Doctors Without Borders/Mdecins Sans Frontires), and ...
... Institute,s Linheng Li Lab has identified the precise location of ... today in the Advance Online Publication of Nature . ... Institute,s support facilities to develop a new technology ex ... the dynamic behavior of stem cells. This technology enabled the ...
... University,s School of Biomedical Engineering and Science,s Center for Injury ... 2008. The Office of the Deputy Chief of ... the award for research that could ultimately help save eyesight ... The center was selected from 57 applicants from around ...
Cached Biology News:Stowers Institute's Linheng Li Lab expands understanding of bone marrow stem cell niche 2New dummy design and development wins US Department of Defense award 2
...
... Digital Sight DS-U2 camera controller is the successor ... designed to interface any of the cameras in ... computer through a USB2.0 interface. The DS-U2 transmits ... cumbersome installation by equipping both hub and mass ...
This unique buffer provides a gentle method for removal of primary and secondary antibodies to allow several reprobings on the same membrane. Gentle buffer will not alter the antigen for subsequent i...
...
Biology Products: